Skip to main content
Caplight Logo









REVIVO BioSystems

REVIVO BioSystems

Private
SingaporeHealthcare & Life Scienceshttps://www.revivobio.com/

Last Round

Seed

Mar 1, 2022

Momentum

Top 25%

of companies Caplight tracks

Company Overview

REVIVO BioSystems is a biotechnology company that provides integrated microfluidic systems and 4D human tissue models for ex vivo and in vitro safety, efficacy, and permeability testing of chemical, cosmetic, and pharmaceutical compounds.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Fashion & Beauty

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

organ-on-a-chipmicrophysiological systemsMPSin vitro testinganimal-free testingmicrofluidicscontract research organizationCROex vivo skin modeldrug discoverysafety assessmentefficacy testingnew approach methodologiesNAMstissue engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

REVIVO BioSystems Comparables

Compare REVIVO BioSystems with similar companies based on industry and business-model similarity.

REVIVO BioSystems comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Outer Biosciences
86%
AIM Biotech
83%
TissUse
83%

REVIVO BioSystems Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 1, 2022

Key People

Founding team and executive leadership

Massimo Alberti

CEO

Executive Team

REVIVO BioSystems Investors

Notable investors and investment history

REVIVO BioSystems investors
InvestorRounds
Evonik Venture CapitalSeed
B7 CapitalSeed
SGInnovateSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 1349% MoM, reaching 913.

  • Mar 1, 2026

    Monthly visitors increased 55% MoM.

REVIVO BioSystems Filings

Explore SEC and related filing metadata, where available.

REVIVO BioSystems filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about REVIVO BioSystems's valuation, stock price, and market status.

Is REVIVO BioSystems a public or private company?

REVIVO BioSystems is a private company.

What is the current stock price of REVIVO BioSystems?

REVIVO BioSystems is a private company with no public stock price. Caplight tracks REVIVO BioSystems's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is REVIVO BioSystems worth (valuation)?

Valuation information for REVIVO BioSystems is not publicly available.

Can I buy REVIVO BioSystems stock?

REVIVO BioSystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was REVIVO BioSystems's last funding round?

REVIVO BioSystems's most recent funding round was Seed on March 1, 2022.

Who are the main investors in REVIVO BioSystems?

Key investors in REVIVO BioSystems include Evonik Venture Capital, B7 Capital, SGInnovate.

Will REVIVO BioSystems IPO soon?

No public IPO plans have been announced for REVIVO BioSystems.

How can I track REVIVO BioSystems secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor REVIVO BioSystems's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSingapore
Employee Range9
Year Founded2019
Last FundingMar 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?